AAME
Price
$2.34
Change
-$0.02 (-0.85%)
Updated
Jul 3 closing price
Capitalization
57.13M
MET
Price
$80.65
Change
+$0.50 (+0.62%)
Updated
Jul 3 closing price
Capitalization
53.28B
24 days until earnings call
Interact to see
Advertisement

AAME vs MET

Header iconAAME vs MET Comparison
Open Charts AAME vs METBanner chart's image
Atlantic American
Price$2.34
Change-$0.02 (-0.85%)
Volume$31.47K
Capitalization57.13M
MetLife
Price$80.65
Change+$0.50 (+0.62%)
Volume$1.62M
Capitalization53.28B
AAME vs MET Comparison Chart in %
Loading...
AAME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AAME vs. MET commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAME is a Hold and MET is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (AAME: $2.34 vs. MET: $80.65)
Brand notoriety: AAME: Not notable vs. MET: Notable
Both companies represent the Life/Health Insurance industry
Current volume relative to the 65-day Moving Average: AAME: 200% vs. MET: 57%
Market capitalization -- AAME: $57.13M vs. MET: $53.28B
AAME [@Life/Health Insurance] is valued at $57.13M. MET’s [@Life/Health Insurance] market capitalization is $53.28B. The market cap for tickers in the [@Life/Health Insurance] industry ranges from $133.31B to $0. The average market capitalization across the [@Life/Health Insurance] industry is $24.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAME’s FA Score shows that 0 FA rating(s) are green whileMET’s FA Score has 1 green FA rating(s).

  • AAME’s FA Score: 0 green, 5 red.
  • MET’s FA Score: 1 green, 4 red.
According to our system of comparison, both AAME and MET are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AAME’s TA Score shows that 5 TA indicator(s) are bullish while MET’s TA Score has 5 bullish TA indicator(s).

  • AAME’s TA Score: 5 bullish, 4 bearish.
  • MET’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, MET is a better buy in the short-term than AAME.

Price Growth

AAME (@Life/Health Insurance) experienced а +15.27% price change this week, while MET (@Life/Health Insurance) price change was +0.86% for the same time period.

The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.76%. For the same industry, the average monthly price growth was +3.04%, and the average quarterly price growth was +9.76%.

Reported Earning Dates

MET is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Life/Health Insurance (+0.76% weekly)

Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MET($53.3B) has a higher market cap than AAME($57.1M). MET has higher P/E ratio than AAME: MET (40.71) vs AAME (20.00). AAME YTD gains are higher at: 54.304 vs. MET (-0.138). MET has more cash in the bank: 308B vs. AAME (24.3M). AAME has less debt than MET: AAME (36.8M) vs MET (18.8B). MET has higher revenues than AAME: MET (66.4B) vs AAME (185M).
AAMEMETAAME / MET
Capitalization57.1M53.3B0%
EBITDAN/AN/A-
Gain YTD54.304-0.138-39,308%
P/E Ratio20.0040.7149%
Revenue185M66.4B0%
Total Cash24.3M308B0%
Total Debt36.8M18.8B0%
FUNDAMENTALS RATINGS
AAME vs MET: Fundamental Ratings
AAME
MET
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
43
Fair valued
PROFIT vs RISK RATING
1..100
8722
SMR RATING
1..100
9199
PRICE GROWTH RATING
1..100
3651
P/E GROWTH RATING
1..100
5194
SEASONALITY SCORE
1..100
5045

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MET's Valuation (43) in the Life Or Health Insurance industry is in the same range as AAME (50) in the Multi Line Insurance industry. This means that MET’s stock grew similarly to AAME’s over the last 12 months.

MET's Profit vs Risk Rating (22) in the Life Or Health Insurance industry is somewhat better than the same rating for AAME (87) in the Multi Line Insurance industry. This means that MET’s stock grew somewhat faster than AAME’s over the last 12 months.

AAME's SMR Rating (91) in the Multi Line Insurance industry is in the same range as MET (99) in the Life Or Health Insurance industry. This means that AAME’s stock grew similarly to MET’s over the last 12 months.

AAME's Price Growth Rating (36) in the Multi Line Insurance industry is in the same range as MET (51) in the Life Or Health Insurance industry. This means that AAME’s stock grew similarly to MET’s over the last 12 months.

AAME's P/E Growth Rating (51) in the Multi Line Insurance industry is somewhat better than the same rating for MET (94) in the Life Or Health Insurance industry. This means that AAME’s stock grew somewhat faster than MET’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AAMEMET
RSI
ODDS (%)
Bearish Trend 4 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
51%
Momentum
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
65%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
58%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
66%
Declines
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 26 days ago
53%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
78%
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
AAME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ROM78.211.91
+2.50%
ProShares Ultra Technology
FDM74.300.80
+1.09%
First Trust Dow Jones Sel MicroCap ETF
DVY136.650.44
+0.32%
iShares Select Dividend ETF
UFIV48.79-0.12
-0.25%
F/m US Treasury 5 Year Note ETF
BITU53.12-0.35
-0.65%
ProShares Ultra Bitcoin ETF

AAME and

Correlation & Price change

A.I.dvisor tells us that AAME and PKIN have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AAME and PKIN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AAME
1D Price
Change %
AAME100%
-0.85%
PKIN - AAME
23%
Poorly correlated
N/A
MET - AAME
20%
Poorly correlated
+0.62%
PRU - AAME
18%
Poorly correlated
+0.39%
AFL - AAME
17%
Poorly correlated
+1.01%
MFC - AAME
15%
Poorly correlated
+1.37%
More

MET and

Correlation & Price change

A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MET
1D Price
Change %
MET100%
+0.62%
PRU - MET
83%
Closely correlated
+0.39%
UNM - MET
81%
Closely correlated
+1.08%
LNC - MET
80%
Closely correlated
-0.57%
PRI - MET
80%
Closely correlated
+0.93%
CNO - MET
77%
Closely correlated
+1.08%
More